Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Section Content Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Radiation-Emitting Products
Tobacco Products
Drugs
Home
Drugs
Guidance, Compliance & Regulatory Information
Guidances (Drugs)
Section Contents Menu
Guidance, Compliance & Regulatory Information
Guidances (Drugs)
Advertising
Bioequivalence Recommendations for Specific Products
Biopharmaceutics
Biosimilarity
CMC - Microbiology (Chemistry, Manufacturing, and Controls)
Chemistry, Manufacturing, and Controls (CMC)
Clinical / Antimicrobial
Clinical / Medical
Clinical Pharmacology
Combination Products
Concept Papers
Current Good Manufacturing Practices (CGMPs)/Compliance
Drug Safety
Electronic Submissions
FDAAA (Food and Drug Administration Amendments Act)
Generics
Good Review Practices
Industry Letters
International Conference on Harmonisation - Efficacy
International Conference on Harmonisation - Joint Safety/Efficacy (Multidisciplinary)
International Conference on Harmonisation - Quality
International Conference on Harmonisation - Safety
Investigational New Drug Applications
Labeling
Microbiology
Modernization Act
Over-the-Counter
Pharm / Tox
Procedural
Small Entity Compliance Guides
User Fees
-
FDAAA (Food and Drug Administration Amendments Act)
Title and Format
Type
Issue Date
Certifications To Accompany Drug, Biological Product, and Device
Applications/Submissions:Compliance with Section 4020) of
The Public Health Service Act,
Added By Title VIII of The Food and Drug Administration
Amendments Act of 2007 (PDF - 314KB)
Draft
4/2008
-
-